INTERACTIVE PEPTIDE SCIENCE
From Concept to Verified Vial
A representative synthetic-peptide journey from molecular idea to analytical testing and documentation.
There is no single manufacturing pathway for every peptide. Peptides may be produced by chemical synthesis, recombinant methods, or extraction from natural sources. This educational experience follows a representative synthetic-peptide pathway to explain common concepts used in peptide manufacturing and analytical testing.
Step 00
More Than One Way to Make a Peptide
Not every peptide is made the same way. Some are chemically synthesized, some are produced using recombinant biological systems, and some may be obtained from natural sources. This walkthrough follows chemical synthesis, a widely used approach for many synthetic peptides.
Key Terms
What this supports
- Multiple production routes exist.
- This walkthrough follows one representative route.
What this does not establish
- That every peptide is manufactured by chemical synthesis.
- That every manufacturer uses the same process.
Important context
This page is educational and does not describe a verified MitoCore manufacturing process.
Step 01
Research Concept
A peptide project begins with a scientific question. Researchers may be interested in a naturally occurring peptide, a known biological pathway, a receptor interaction, or a modified sequence designed to study a particular property.
Key Terms
What this supports
- Peptide design begins with a defined scientific objective.
- The objective influences downstream design and characterization.
What this does not establish
- That every peptide begins as a pharmaceutical drug-development program.
- That a biological hypothesis guarantees a useful or safe product.
Important context
Keep the visual conceptual; do not suggest guaranteed biological outcomes.
Step 02
Sequence & Molecular Design
A peptide is built from amino acids arranged in a specific order. Changing the sequence — or adding certain chemical modifications — can change the molecule's physical and biological properties.
Key Terms
What this supports
- Sequence is central to peptide identity.
- Modifications can alter peptide properties.
What this does not establish
- That a sequence alone predicts all biological effects.
- That every modification improves a peptide.
Important context
Do not provide a protocol for designing or optimizing novel bioactive peptides.
Step 03
Building the Peptide Chain
One common way to make a synthetic peptide is solid-phase peptide synthesis. The growing peptide is attached to a solid support while amino acids are added step by step until the sequence is assembled.
Residues assembled: 0 / 6
Key Terms
What this supports
- SPPS is a common synthetic-peptide manufacturing approach.
- Peptide assembly is iterative.
What this does not establish
- That every peptide is manufactured by SPPS.
- That this educational animation represents executable laboratory instructions.
Important context
No reagent quantities, temperatures, timings, solvent recipes, or laboratory conditions may be displayed.
View sources
- Peer-reviewedStawikowski M, Fields GB — Introduction to Peptide Synthesis
- Peer-reviewedPennington MW et al. — Commercial manufacturing of current good manufacturing practice peptides
Step 04
The Crude Mixture
Synthesis does not automatically produce only the desired peptide. The crude material can contain the target peptide along with related and process-derived impurities.
Key Terms
What this supports
- Crude synthetic peptide may contain multiple components.
- Purification and analysis are important downstream steps.
What this does not establish
- That any specific impurity is present in a real MitoCore product.
- That all impurities have the same risk or significance.
Important context
All impurity examples are educational categories, not lot-specific findings.
View sources
- FDAFDA — Guidance for Industry: Synthetic Peptides
- FDAFDA — Assessing Immunogenicity Risk of Peptides: the Synthetic Peptide Guidance and Product-Specific Guidances
- Peer-reviewedPennington MW et al. — Commercial manufacturing of current good manufacturing practice peptides
Step 05
Separating the Target Peptide
Purification separates the desired peptide from other components in the crude mixture. Chromatography — including reversed-phase HPLC — is commonly used for peptide separation.
The illustrative purified state shows one dominant main peak and smaller secondary peaks.
Key Terms
What this supports
- Chromatography can separate peptide components.
- Purification methods can reduce related impurities.
What this does not establish
- That one chromatogram proves every quality attribute.
- That RP-HPLC is the only peptide-purification method.
Important context
Do not display a fictional chromatogram without an "Illustrative" label.
View sources
Step 06
Is It Consistent With the Expected Peptide?
Analytical testing can examine whether the material is consistent with the expected peptide. Mass spectrometry is one important tool because it can measure molecular mass with high precision.
Expected
4,112.2 Da
Observed
4,112.3 Da
Key Terms
What this supports
- Mass spectrometry can support peptide identity characterization.
- A result consistent with expected mass can strengthen identity evidence.
What this does not establish
- That mass spectrometry alone proves overall purity.
- That it proves sterility, endotoxin status, vial content, or clinical safety.
Important context
Use "supports identity" or "is consistent with expected mass," not "proves the peptide is correct."
Step 07
From Purified Material to a Finished Vial
Depending on the product and research purpose, purified peptide may be formulated, filled into vials, and lyophilized — a controlled drying process that removes water after freezing.
Appearance alone does not prove purity, identity, content, sterility, or quality.
Key Terms
What this supports
- Lyophilization is used in some peptide products.
- Stability depends on multiple formulation and environmental factors.
What this does not establish
- That every peptide is lyophilized.
- That a white or intact cake proves purity, identity, content, sterility, or quality.
Important context
No universal post-reconstitution storage duration may be shown.
View sources
- Peer-reviewedMcCarthy D et al. — Reference Standards to Support Quality of Synthetic Peptide Therapeutics
- Peer-reviewedDesigning Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review
- Peer-reviewedFactors affecting the physical stability (aggregation) of peptide therapeutics
Step 08
Connecting Material to Records
A lot or batch identifier helps connect a specific quantity of material to its manufacturing and testing records.
Key Terms
What this supports
- Lot identifiers can support traceability when records are reliable.
- Testing should be linked to the material actually tested.
What this does not establish
- That a printed lot number alone proves authenticity.
- That MitoCore currently has public lot verification.
Important context
All identifiers on this page are fictional.
View sources
- USPUSP — Reference Standards to Support Quality of Synthetic Peptide Therapeutics
- Editorial policyMitoCore Stage 25B scientific evidence boundary ruling (internal editorial policy, not a citation)
Step 09
Different Tests Answer Different Questions
There is no single "peptide quality test." Identity, purity, amount, sterility, endotoxin, and other characteristics are different questions that require different analytical approaches.
One Test Cannot Answer Every Question
- Strong direct relevance = Primary analytical question
- Partial relevance = May contribute supporting information
- Not answered = This test does not answer that question
- IdentityPrimary
- Chromatographic PuritySupporting
- Amount / ContentNot answered
- SterilityNot answered
- Bacterial EndotoxinNot answered
- Physical / Stability AttributesNot answered
- Biological Activity — when relevantNot answered
This matrix is conceptual. Exact analytical strategies depend on the peptide, product, manufacturing route, formulation, and intended research or regulatory context.
Key Terms
What this supports
- Multiple tests may be needed to characterize different attributes.
- One analytical result does not answer every quality question.
What this does not establish
- That every peptide requires the same test panel.
- That one passing result establishes overall product quality.
Important context
This is a conceptual test matrix, not a universal release specification.
View sources
- FDAFDA — Guidance for Industry: Synthetic Peptides
- FDAFDA — 2026 revised product-specific guidance announcement for peptide drug products
- USPUSP — Reference Standards to Support Quality of Synthetic Peptide Therapeutics
- USPUSP — Microbiological Quality Control Testing
- USPUSP — <71> Sterility Test harmonization information
Step 10
Turning Test Results Into a Report
A Certificate of Analysis, or COA, summarizes analytical information for a sample or lot. Useful reports identify what was tested, which method was used, what result was obtained, and how that result relates to a specification or acceptance criterion when one exists.
Certificate of Analysis — Educational Example
Educational exampleKey Terms
What this supports
- A COA can organize and communicate analytical results.
- Method, sample identity, and traceability matter when interpreting it.
What this does not establish
- That a document labeled "COA" is automatically authentic.
- That a COA automatically proves safety, sterility, or complete quality.
Important context
The Stage 25 COA is illustrative only.
View sources
- USPUSP — Reference Standards to Support Quality of Synthetic Peptide Therapeutics
- USPUSP — Microbiological Quality Control Testing
- Editorial policyMitoCore Stage 25B scientific evidence boundary ruling (internal editorial policy, not a citation)
Step 11
Verification Is More Than a Number
Strong verification connects the material, the sample, the laboratory, the method, the result, and the documentation. A purity percentage by itself is not the same as complete verification.
Verification is a chain of evidence, not a single number.
Key Terms
What this supports
- Reliable verification is a chain of evidence.
- Analytical results are strongest when linked to trustworthy records.
What this does not establish
- That MitoCore currently offers public lot-level verification.
- That a single test result substitutes for full traceability.
Important context
Future MitoCore lot verification, if developed, must be implemented and released separately.
View sources
- USPUSP — Reference Standards to Support Quality of Synthetic Peptide Therapeutics
- Editorial policyMitoCore Stage 25B scientific evidence boundary ruling (internal editorial policy, not a citation)
The Big Idea
A peptide does not become well-characterized because one number looks good. Sequence, synthesis, purification, identity, chromatographic composition, quantity, formulation, microbiological quality, documentation, and traceability answer different questions.
Not the useful question
“Does this peptide have a COA?”
The useful question
“What was tested, how was it tested, what does the result support, and what questions remain unanswered?”
This interactive experience is educational and illustrates a representative synthetic-peptide workflow. It does not describe or certify the manufacturing or testing history of a specific MitoCore product or lot.